[Measurement of glomerular filtration rate using a reference method].

Mesure du débit de filtration glomérulaire par méthode de référence.

Journal

Annales de biologie clinique
ISSN: 1950-6112
Titre abrégé: Ann Biol Clin (Paris)
Pays: France
ID NLM: 2984690R

Informations de publication

Date de publication:
01 08 2019
Historique:
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 22 1 2020
Statut: ppublish

Résumé

Direct measurement methods of glomerular filtration rate (GFR) are considered as the gold standard to assess kidney function. Following the withdrawal of the Proinuline Serb® specialty by the French National Health Surveillance Agency, iohexol remains the most suitable marker to replace inulin as the marker for GFR in France. The assay is performed by high performance liquid chromatography (HPLC) coupled with ultraviolet (UV) detection or by mass spectrometry. Plasma clearance measurement is the protocol of choice: single-sample protocols dominate, but multiple-sample protocols may be more accurate in specific situations to improve accuracy. In some cases, urinary clearance protocols may be proposed. National and international recommendations suggest using a GFR measurement as a confirmatory test in cases where the creatinine-based estimated GFR is inappropriate, ie clinical situations characterized by a significant alteration of muscle mass or volume distribution. The indications retained by the working group were graded according to the level of recommendations. The essential indications are the evaluation of living kidney donor, the monitoring of kidney allograft function at one year post-transplantation, drugs with narrow therapeutic range (anticoagulant, chemotherapy) in patients with inadequate estimation of GFR by creatinine and clinical research.

Identifiants

pubmed: 31418697
pii: abc.2019.1455
doi: 10.1684/abc.2019.1455
doi:

Substances chimiques

Biomarkers 0
Iohexol 4419T9MX03
Creatinine AYI8EX34EU

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

371-374

Auteurs

Laurence Chardon (L)

Hospices civils de Lyon, Hôpital Edouard Herriot, Service de biochimie, Lyon, France.

Laurence Dubourg (L)

Hôpital Femme Mère Enfant, Bron, France ; Néphrologie, Dialyse, HTA et Exploration fonctionnelle rénale, Hôpital Edouard Herriot ; Faculté de médecine Lyon Est, Université Lyon 1, Lyon, France.

Chantal Barin-Le Guellec (C)

University of Tours, Tours, France ; Department of molecular biology, Tours, France ; Inserm, UMR 1248, Université de Limoges, Limoges, France.

Francis Guinard (F)

Laboratoire de biologie médicale Bioexcel, Saint-Doulchard, France.

Thierry Hannedouche (T)

Service de néphrologie, Hôpitaux universitaires de Strasbourg, Faculté de médecine, Strasbourg, France.

Jean-Michel Halimi (JM)

Néphrologie-Immunologie clinique, Hôpital Bretonneau, CHRU Tours, Tours ; EA4245, François-Rabelais University, Tours, France.

Christophe Mariat (C)

Department of nephrological intensive care, University Jean Monnet, Hôpital Nord, Saint-Étienne, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH